2020
DOI: 10.1002/jbmr.4289
|View full text |Cite
|
Sign up to set email alerts
|

Bone microarchitecture in patients with autoimmune hepatitis

Abstract: In patients with autoimmune hepatitis (AIH), osteoporosis represents a common extrahepatic complication, which we recently demonstrated by an assessment of areal bone mineral density (aBMD) via dual-energy X-ray absorptiometry (DXA). However, it is well established that bone quality and fracture risk does not solely depend on aBMD, but also on bone microarchitecture. It is currently not known whether AIH patients exhibit a site-or compartment-specific deterioration in the skeletal microarchitecture. In order t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 47 publications
1
4
0
1
Order By: Relevance
“…Our histomorphometric analysis showed a significant association between the severity of liver tissue disturbance associated with ALC and osteocytic Cx43 and sclerostin expression levels in investigated femoral and vertebral bone samples (Figure 4). These findings suggest that the staging of liver disease could significantly contribute to ALC‐induced bone loss (Figure 5), which was previously indicated by various studies dealing with individuals with alcoholic and nonalcoholic liver disease (Culafić et al, 2014; Jadzic, Cvetkovic, Tomanovic, et al, 2020; Jadzic, et al, 2021; Schmidt et al, 2021). However, the assessed osteocytic lacunar network parameters and bone marrow adiposity parameters in lumbar vertebrae did not significantly correlate with the HAI values of the ALC group.…”
Section: Discussionsupporting
confidence: 67%
See 1 more Smart Citation
“…Our histomorphometric analysis showed a significant association between the severity of liver tissue disturbance associated with ALC and osteocytic Cx43 and sclerostin expression levels in investigated femoral and vertebral bone samples (Figure 4). These findings suggest that the staging of liver disease could significantly contribute to ALC‐induced bone loss (Figure 5), which was previously indicated by various studies dealing with individuals with alcoholic and nonalcoholic liver disease (Culafić et al, 2014; Jadzic, Cvetkovic, Tomanovic, et al, 2020; Jadzic, et al, 2021; Schmidt et al, 2021). However, the assessed osteocytic lacunar network parameters and bone marrow adiposity parameters in lumbar vertebrae did not significantly correlate with the HAI values of the ALC group.…”
Section: Discussionsupporting
confidence: 67%
“…However, the assessed osteocytic lacunar network parameters and bone marrow adiposity parameters in lumbar vertebrae did not significantly correlate with the HAI values of the ALC group. Results of other research teams that used peripheral quantitative CT to assess bone deterioration in alcoholic and nonalcoholic liver cirrhosis patients did not show significant correlations between micro-structural bone loss and clinical stages (Schmidt et al, 2021;Wakolbinger et al, 2019), suggesting that the clinical utility of our findings requires further confirmation in large prospective studies in controlled clinical settings.…”
Section: Assessment Of Bone Marrow Adipositymentioning
confidence: 59%
“…However, patients with AIH without glucocorticoid use also had an increased risk of osteoporotic fracture. Recently, possible associations between AIH and osteoporosis have been reported in small-scale studies (16)(17)(18). Notably, patients with AIH have a severe age-dependent deterioration of the cortical bone microarchitecture exceeding the age-associated bone loss in healthy controls.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, patients with AIH have a severe age-dependent deterioration of the cortical bone microarchitecture exceeding the age-associated bone loss in healthy controls. This may contribute to an increased risk of osteoporotic fractures (18). Cortical bone loss is known to be a significant contributor to bone strength, and the majority of bone loss after age $65 years is cortical (19).…”
Section: Discussionmentioning
confidence: 99%
“…Dies gilt insbesondere für Patient*innen unter Steroidtherapie. Zudem sollte bei Erstdiagnose einer autoimmunen Lebererkrankung eine Knochendichtemessung (mittels Dual Energy X-Ray Absorptiometrie = DXA) veranlasst und im Verlauf je nach Befund und Therapie, spätestens jedoch alle 5 Jahre, wiederholt werden 4951 .…”
Section: Monitoring Von Patienten Mit Autoimmunen Lebererkrankungenunclassified